BDNF levels decreased in several cognitive disorders as a non-specific marker for neurodegeneration. The use of psychotropic drugs during BDNF studies could create a confounding effect, therefore, needs to be controlled before BDNF analysis. BDNF can potentially be used as a new therapeutic target because it involves dementia and PD neuropathology. Here, BDNF is linked to Parkinson disease.